FDA extends deadline for Philip Morris IQOS comments

The US Food and Drug Administration (FDA) has extended the deadline for comments on Philip Morris International’s (PMI’s) modified risk tobacco product application (MRTPA) for its IQOS heated tobacco device and Heatstick consumables. ...

Restricted content. Do you want to read more?